Panalpina Welttransport (Holding) AG : Expensive stock, subject to negative repercussions from Trump election
Entry price | Target | Stop-loss | Potential |
---|
CHF 125.3 |
CHF 114.4 |
CHF 130 |
+8.7% |
---|
The stock of Panalpina looks headed South. With a 2017 PE ratio of 24x and roughly 40% in sales stemming from the Americas, the likeliest scenario is for the stock price to fall further towards the CHF 114 level.
Strengths● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.51 for the 2016 fiscal year.
● Within the weekly time frame the stock shows a bullish technical configuration above the support level at 114.4 CHF
Weaknesses● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● The company's earnings releases usually do not meet expectations.
● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 36.7 times its estimated earnings per share for the ongoing year.
● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
● For the last few months, analysts have been revising downwards their earnings forecast.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.